Results 31 to 40 of about 68,638 (278)

Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer [PDF]

open access: yes, 2017
background: The present study aimed to examine the relationship between tumour invasiveness (T stage), the local and systemic environment and cancer-specific survival (CSS) of patients with primary operable colorectal cancer.
A Chrysanthopoulou   +47 more
core   +1 more source

Clinical management of endoscopically resected pT1 colorectal cancer [PDF]

open access: yes, 2018
Background Implementation of colorectal cancer (CRC) screening programs increases endoscopic resection of polyps with early invasive CRC (pT1). Risk of lymph node metastasis often leads to additional surgery, but despite guidelines, correct management ...
Angeletti, Stefano   +11 more
core   +1 more source

A classification based on tumor budding and immune score for patients with hepatocellular carcinoma

open access: yesOncoImmunology, 2020
Background: The role of immune profiling and tumor budding in hepatocellular carcinoma (HCC) remains largely unknown. This study evaluated the association between tumor budding and lymphocytic infiltration in HCC.
Li Wei   +5 more
doaj   +1 more source

Significance of tumor budding in colorectal carcinoma – A tertiary care center study

open access: yesAsian Journal of Medical Sciences, 2022
Background: Colorectal carcinoma is one of the leading causes of mortality worldwide. Although the current TNM staging helps in prognostic stratification, these cancers are known to show heterogeneous behavior within the same stage.
Preeta Naik   +3 more
doaj   +1 more source

Immune checkpoints in circulating and tumor-Infiltrating CD4 + T Cell Subsets in Colorectal cancer patients [PDF]

open access: yes, 2019
Blockade of inhibitory immune checkpoints (ICs) is a promising therapeutic approach; however, it has shown limited success in some cancers including colorectal cancer (CRC). The tumor microenvironment (TME) is largely responsible for response to therapy,
Abu Nada, M   +5 more
core   +2 more sources

Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Type 3 innate lymphoid cells (ILC3s) are essential for host defense against infection and tissue homeostasis. However, their role in the development of HCC has not been adequately confirmed. In this study, we investigated the immunomodulatory role of short‐chain fatty acids (SCFAs) derived from intestinal microbiota in ILC3
Chupeng Hu   +11 more
wiley   +1 more source

The Role of Tumour Budding as a Prognostic Factor in Primary Invasive Ductal Carcinoma of Breast

open access: yesOnline Journal of Health & Allied Sciences, 2022
Background: Tumor budding is considered as an essential step in invasion and as a poor prognostic factor in carcinoma.It is used as the main prognostic factor in colon cancer but it is now gaining popularity in other tumor types.
Chandana N, Vijay Shankar S, Amita K
doaj  

The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer [PDF]

open access: yes, 2017
Aims: Although the role of phosphorylation of oestrogen receptor (ER) at serines 118 (p-S118) and 167 (p-S167) has been studied, the relationship between p-S118, p-S167 and the tumour microenvironment in ER-positive primary operable ductal breast ...
Arnold   +38 more
core   +1 more source

TUMOR BUDDING Y EL CÁNCER COLORRECTAL [PDF]

open access: yesRevista chilena de cirugía, 2014
Budding tumour and colorectal cancer introduction: Tumour budding (TB) is defined as the presence of clusters of tumoural cells detaching from invasive margin of main tumor. It is an independent adverse prognostic factor in colorectal cancer. The aim of this study is to determinate if severity of tumor budding is associated with others prognostic ...
Labalde M, Maria   +5 more
openaire   +2 more sources

TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk

open access: yesHepatology, EarlyView., 2022
The systematic approach in elucidating the gain‐of‐function (GOF) roles of TP53 mutations in early liver carcinogenesis. Unique downstream targets of TP53 L3 mutations were identified from chormatin immunoprecipitation sequencing in HCC cell lines, followed by a series of validation assays to substantiate the exclusive transcriptional regulations ...
Yin Kau Lam   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy